FDA extends review process for Novartis drug by three months - NEWS1105

NEWS1105

News1105 latest news as it happens

Comments system

test banner

Post Top Ad

Responsive Ads Here

FDA extends review process for Novartis drug by three months

Share This

FDA extends review process for Novartis drug by three months



The review process for a drug to treat patients with relapsing multiple sclerosis was extended by three months.

via FOX NEWS https://ift.tt/2MpEDXJ

No comments:

Post a Comment

Post Bottom Ad

Responsive Ads Here

Pages